Correction of an iron-deficiency state in women during pregnancy

Khabarov S.V.

1) Medical Institute, Tula State University, Tula, Russia; 2) Academy of Postgraduate Education, Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of Russia, Moscow, Russia; 3) VitroClinic, IVF “Genome” Clinics Network, “Medma” Companies Group, Moscow, Russia
Objective: To estimate the level and rate of an iron deficiency state in pregnant women in the initial gestation period and to analyze the therapeutic efficacy of the use and clinical tolerability of the iron agent ferrous protein succinylate/folinic acid in the patients of this group. Materials and methods: A total of 524 women who were registered for pregnancy in the VitroClinic were examined. All the patients underwent serum ferritin concentration determinations in addition to general clinical blood testing. During their therapy, 221 pregnant women with identified iron deficiency were divided into two groups. The study group patients (n=112) took ferrous protein succinylate in combination with folinic acid; the comparison group patients (n=109) received other agents based on inorganic iron (II) salts. Results: According to our data, at the beginning of the gestation, iron deficiency was identified in 67.2% of the pregnant women; moreover, half of them had latent iron deficiency detectable by the ferritin concentration. The pregnant women’s use of the drug Ferlatum Fol based on a combination of ferrous protein succinylate and folinic acid demonstrated a more significant therapeutic effect; as a result of two-month intake of the drugs; the average increase in ferritin levels was 110.5%, relatively 61.0% in the women who received other iron agents, that in hemoglobin was 12.6% and 5.1% and in packed cell volume was 9.1% and 6.1%, respectively (p<0.001). Adverse reactions were detected in 7/112 (6.3%) pregnant women taking Ferlatum Fol and in 12/109 (11.1%) patients taking iron (II) salts. Conclusion: Ferlatum Fol is highly effective in rapidly correcting hyposiderosis in the patients in the gestation period, has a high safety profile and an extremely low rate of side effects. Conflicts of interest: The author declares that there are no possible conflicts of interest. Funding: The investigation has not been sponsored. Ethical Approval: The investigation has been approved by the Ethics Committee, Medical Institute, Tula State University. Patient Consent for Publication: The patients have signed an informed consent form to the publication of their data. Authors' Data Sharing Statement: The data supporting the conclusions of this investigation are available upon request from the author. For citation: Khabarov S.V. Correction of an iron-deficiency state in women during pregnancy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2023; (6): 115-122 (in Russian)


iron-deficiency states
ferrous protein succinylate
ITF 282
folinic acid
Ferlatum Fol


  1. Camaschella C. Iron deficiency. Blood. 2019; 133(1): 30-9.
  2. Резолюция Совета экспертов «Лечение и профилактика железодефицитных состояний на современном этапе в условиях реальной клинической практики. Место комбинированных лекарственных препаратов железа в сочетании с фолиевой кислотой при лечении железодефицитной анемии и дефицита железа». Акушерство и гинекология. 2023; 3: 155-62. [Resolution of the Council of Experts "Treatment and prevention of iron deficiency conditions at the present stage in real clinical practice. The place of combined iron medications in combination with folic acid in the treatment of iron deficiency anemia and iron deficiency". Obstetrics and Gynecology. 2023; (3): 155-62. (in Russian)].
  3. WHO Global Anaemia estimates. Anaemia in women and children. Geneva, Switzerland: World Health Organization; 2021 Edition. Available at: gho/data/themes/topics/anaemia_in_women_and_children Accessed 03.05.2023.
  4. WHO Global health observatory. Maternal and reproductive health. Geneva, Switzerland: World Health Organization; 2020. Available at: maternal-and-reproductive-health Accessed 03.05.2023.
  5. Резолюция совета экспертов по железодефицитной анемии у женщин. Акушерство и гинекология: новости, мнения, обучение. 2020; 8(4): 28-36. [Resolution of the Council of Experts on iron-deficiency anemia in women. Obstetrics and Gynecology: News, Opinions, Training. 2020; 8(4): 28-36.(in Russian)].
  6. Хабаров С.В., Денисова О.В., Девиченский В.М. Современные тенденции в лабораторной диагностике анемии во время беременности (тезисы доклада конгресса). Акушерство и гинекология. 2019; 4(приложение): 87-8. [Khabarov S.V., Denisova O.V., Devichenskij V.M. Current trends in laboratory diagnosis of anemia during pregnancy (abstracts of the Congress report). Obstetrics and Gynecology. 2019; 4(Suppl.): 87-8. (in Russian)].
  7. Резолюция совета экспертов «Железодефицитные состояния у беременных: новая комбинация – новые возможности». Акушерство и гинекология: новости, мнения, обучение. 2021; 9(4): 79-82. [Resolution of the Council of Experts "Iron deficiency conditions in pregnant women: a new combination – new opportunities". Obstetrics and Gynecology: News, Opinions, Training. 2021; 9(4): 79-82. (in Russian)].
  8. FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Good clinical practice advice: iron deficiency anemia in pregnancy. Int. J. Gynaecol. Obstet. 2019; 144(3): 322-4.
  9. Sun Y., Shen Z.Z., Huang F.L., Jiang Y., Wang Y.W., Zhang S.H. et al. Association of gestational anemia with pregnancy conditions and outcomes: a nested case-control study. World J. Clin. Cases. 2021: 9(27): 8008-19.
  10. Министерство здравоохранения Российской Федерации. Основные показатели здоровья матери и ребенка, деятельность службы охраны детства и родовспоможения в РФ в 2021 г. М.; 2022. [Ministry of Health of the Russian Federation. The main indicators of maternal and child health, the activities of the child protection and maternity services in the Russian Federation in 2021. Moscow; 2022. (in Russian)].
  11. Young M.F., Oaks B.M., Tandon S., Martorell R., Dewey K.G., Wendt A.S. Maternal hemoglobin concentrations across pregnancy and maternal and child health: a systematic review and meta-analysis. Ann. N. Y. Acad. Sci. 2019; 1450(1): 47-68.
  12. Резолюция Совета экспертов по профилактике и лечению железодефицитной анемии у беременных. Акушерство и гинекология. 2020; 4: 230-2. [Expert council resolution on prevention and treatment of iron deficiency anemia in pregnant women. Obstetrics and Gynecology. 2020; (4): 230-2.(in Russian)].
  13. Резолюция совета экспертов «Алгоритмы ведения беременных, женщин в послеродовом периоде и кормящих с железодефицитной анемией на амбулаторном этапе». Акушерство и гинекология. 2019; 8: 182-6. [Resolution of the Expert Council on «Algorithms for the management of pregnant, postpartum, and breast- feeding women with iron deficiency anemia in an outpatient setting». Obstetrics and Gynecology. 2019; (8): 182-6. (in Russian)]. aig.2019.8.182-186.
  14. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva, Switzerland: World Health Organization; 2020. Available at: Accessed 23.04.2023.
  15. Хабаров С.В., Денисова О.В. Современная тактика лабораторной диагностики нарушений обмена железа во время беременности. Медицинский алфавит. 2019; 1(4): 49-53. [Khabarov S.V., Denisova O.V. Modern tactics of laboratory diagnostics of iron metabolism disorders during pregnancy. Medical Alphabet. 2019; 1(4): 49-53. (in Russian)].
  16. Хабаров С.В., Денисова О.В. Ферритин и его роль в лабораторной диагностике железодефицитных состояний у беременных. В кн.: Сборник научных трудов Академии постдипломного образования ФГБУ ФНКЦ ФМБА России. Сборник научных статей. вып. 3. М.: Изд-во «Перо»; 2021: 39-49. [Khabarov S.V., Denisova O.V. Ferritin and its role in the laboratory diagnosis of iron deficiency conditions in pregnant women. In: Collection of scientific papers of the Academy of Postgraduate Education of the FSBI FNCC FMBA of Russia. Collection of scientific articles. vol. 3. Moscow: Pero Publishing House; 2021: 39-49. (in Russian)].
  17. Хабаров С.В., Волков В.Г., Сурвилло Е.В., Малых Н.Е., Бадаева А.А., Сенаторова Л.В., Лохмачева Е.А. Анемии у беременных: учебное пособие. Изд-во ИП Колмогоров И.А. (Новый формат); 2022. 130 с. [Khabarov S.V., Volkov V.G., Survillo E.V., Malyh N.E., Badaeva A.A., Senatorova L.V., Lokhmacheva E.A. Anemia in pregnant women: a textbook. IP Kolmogorov I.A. (New format); 2022. 130 p. (in Russian)].
  18. Pavord S., Daru J., Prasannan N., Robinson S., Stanworth S., Girling J.; BSH Committee. UK guidelines on the management of iron deficiency in pregnancy. Br. J. Haematol. 2020; 188(6): 819-30.
  19. Хабаров С.В. Лабораторная диагностика и лечение анемии во времябеременности: современные тренды. Тезисы III Национального Конгресса с международным участием «ЛАБРиН-2021. Инфекции. Год с COVID-19: итоги». Россия, Москва, 31 марта – 2 апреля 2021. Акушерство и гинекология. 2021; 3(приложение): 28-9. [Khabarov S.V. Current trends in laboratory diagnosis of anemia during pregnancy. The Third National Congress with international participation “LABR&N-2021. Infection. The year with COVID-19: Results”. Russia, Moscow, 31 March – 2 April, 2021. Obstetrics and Gynecology. 2021; 3(Suppl): 28-9. (in Russian)].
  20. Инструкция по медицинскому применению препарата Ферлатум Фол. [Instructions for the medical use of the drug Ferlatum Fol. (in Russian)]. Available at: Accessed 27.04.2023.
  21. Raja K.B., Jafri S.E., Dickson D., Acebròn A., Cremonesi P., Fossati G. et al. Involvement of iron (ferric) reduction in the iron absorption mechanism of a trivalent iron-protein complex (iron protein succinylate). Pharmacol. Toxicol. 2000; 87(3): 108-15.
  22. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Гоголева И.В. Систематический анализ фармакологических свойств протеин сукцинилата железа. Эффективная фармакотерапия. 2018; 13: 20-9. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Gogoleva I.V. Systematic analysis of pharmacological properties of iron succinylate protein. Effective pharmacotherapy. 2018; (13): 20-9. (in Russian)].
  23. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Павлович С.В. Систематический анализ молекулярного синергизма фолиевой кислоты и фумарата железа при железодефицитной анемии. Акушерство и гинекология. 2022; (12): 178-86. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Pavlovich S.V. Systematic analysis of the molecular synergism of folic acid and iron fumarate in iron deficiency anemia. Obstetrics and Gynecology. 2022; (12): 178-86. (in Russian)].
  24. WHO antenatal care recommendations for a positive pregnancy experience: Nutritional interventions update: Multiple micronutrient supplements during pregnancy. Geneva, Switzerland: World Health Organization; 2020. Available at: Accessed 27.04.2023.
  25. Громова О.А., Торшин И.Ю. Микронутриенты и репродуктивное здоровье: руководство. М.: ГЭОТАР-Медиа; 2019. 672 с. [Gromova O.A., Torshin I.Yu. Micronutrients and reproductive health: a guide. Moscow: GEOTAR-Media; 2019. 672 p. (in Russian)].
  26. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Железодефицитная анемия». М.; 2021. [Ministry of Health of the Russian Federation. Iron deficiency anemia. Clinical Guidelines. Moscow; 2021. (in Russian)]. Available at: Accessed 27.04.2023.
  27. Хельсинкская декларация Всемирной медицинской ассоциации. Этические принципы проведения медицинских исследований с участием человека в качестве субъекта. (Принята на 18-й Генеральной Ассамблее ВМА, Хельсинки, Финляндия, июнь 1964 г., последние изменения внесены на 64-й Генеральной Ассамблее ВМА, Форталеза, Бразилия, октябрь 2013 г.). Клиническая информатика и телемедицина. 2014; 10(11): 119-22. [Helsinki Declaration of the World Medical Association. Ethical principles of conducting medical research with the participation of a person as a subject. (Adopted at the 18th General Assembly of the WMA, Helsinki, Finland, June 1964, the last changes were made at the 64th General Assembly of the WMA, Fortaleza, Brazil, October 2013). Clinical Informatics and Telemedicine. 2014; 10(11): 119-22. (in Russian)].
  28. ICH Harmonised Guideline. Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2). 2016. 60p. Available at: Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4_2016_1109.pdf Accessed 27.04.2023.
  29. Национальный стандарт Российской Федерации ГОСТ Р 52379-2005«Надлежащая клиническая практика». [The national standard of the Russian Federation GOST R 52379-2005 "Good clinical practice".(in Russian)]. Available at: Accessed 27.04.2023.
  30. Schiassi M., Muzio F., Curiale C., De Bartolo G. Clinical tolerability and efficacy of iron proteinsuccinylate: a retrospective analysis of over 3000 published cases. Proceedings of the European Iron Club Meeting, Porto, 4–7 September 1990; Parte IV Clinical Documentation; Vol. 2: Ref. 21.
  31. Juarez-Vazquez J., Bonizzoni E., Scotti A. Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial. BJOG. 2002; 109(9): 1009-14.
  32. Martínez Francés A., Leal Martínez-Bujanda J. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research. Curr. Med. Res. Opin. 2020; 36(4): 613-23.
  33. Sallusto A., Eandi M., De Bartolo G., Curiale C., Massobrio M. Ferroprotein succinylate: treatment of iron deficiency in obstetrics and gynecology. Minerva Ginecol. 1990; 42(5): 191-5. (in Italian).
  34. Urso K., Leal Martínez-Bujanda J., Del Prado J.M. Iron protein succinylate in the management of Iron deficiency anemia: a comparative study with ferrous sulphate at low and high therapeutic doses. Nutrients. 2021; 13(3): 968.

Received 13.06.2023

Accepted 20.06.2023

About the Authors

Sergey V. Khabarov, Dr. Med. Sci., Merited Doctor of the Russian Federation, Associate Professor, Professor at the Department of Obstetrics and Gynecology, Medical Institute of Tula State University; Professor at the Department of Clinical Laboratory Diagnostics and Pathological Anatomy, Academy of Postgraduate Education of the FMBA, +7(916)726-51-26,,, SPIN-code: 1896-1300, Scopus Author ID: 57220038210, AuthorID: 1025053, Researcher ID: ABB-2726-2021, 128 Boldin str., Tula, 300028, Russia.

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.